Chargement en cours...
Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...
Enregistré dans:
| Publié dans: | Patient Saf Surg |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111901/ https://ncbi.nlm.nih.gov/pubmed/33975621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13037-021-00295-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|